Kezar Life Sciences Inc
KZR
Company Profile
Business description
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Contact
4000 Shoreline Court
Suite 300
South San Francisco CA 94080
USAT: +1 650 822-5600
E: IR@kezarbio.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
58
Stocks News & Analysis
stocks
This ASX share has been awarded a moat by our analysts
Along with the narrow moat rating we raised our fair value by 12%.
video
Now the dust has settled, a mini earnings wrap
Three of our equity analysts reflect on the best results, worst disappointments and biggest market overreactions from their sectors.
stocks
This moated ASX stock is swimming in cash
This cash cow has a fortress balance sheet and is undervalued according to our analyst.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,362.90 | 21.80 | 0.26% |
| CAC 40 | 7,449.44 | 15.81 | -0.21% |
| DAX 40 | 18,633.11 | 66.29 | -0.35% |
| Dow JONES (US) | 41,622.08 | 228.30 | 0.55% |
| FTSE 100 | 8,278.44 | 5.35 | 0.06% |
| HKSE | 17,601.88 | 179.76 | 1.03% |
| NASDAQ | 17,592.13 | 91.85 | -0.52% |
| Nikkei 225 | 35,939.01 | 642.75 | -1.76% |
| NZX 50 Index | 12,648.30 | 56.09 | -0.44% |
| S&P 500 | 5,633.09 | 7.07 | 0.13% |
| S&P/ASX 200 | 8,140.90 | 19.30 | 0.24% |
| SSE Composite Index | 2,704.09 | 13.03 | -0.48% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Imugene Ltd IMU | 0.05 | 0.00 | -2.00% |
| Resolute Mining Ltd RSG | 0.74 | 0.01 | 1.72% |
| Telstra Group Ltd TLS | 3.99 | 0.03 | -0.62% |
| Pilbara Minerals Ltd PLS | 2.85 | 0.04 | -1.22% |
| Appen Ltd APX | 1.56 | 0.05 | 3.32% |
| Botanix Pharmaceuticals Ltd BOT | 0.40 | 0.02 | -3.61% |
| Core Lithium Ltd CXO | 0.10 | 0.00 | -2.04% |
| Sayona Mining Ltd SYA | 0.02 | 0.00 | -2.08% |
| Platinum Asset Management Ltd PTM | 1.11 | 0.12 | 12.37% |
| Red 5 Ltd RED | 0.33 | 0.00 | 0.77% |